Bottom line
How much do BBH and PBE overlap?
40% of their top holdings overlap by weight. 12 securities appear in both funds' top 25, making up 64.3% of BBH's assets and 47.9% of PBE's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings BBH and PBE have in common
| Holding | % of BBH | % of PBE | Overlap |
|---|---|---|---|
| Amgen Inc | 15.25% | 5.22% | 5.22% |
| Gilead Sciences Inc | 12.79% | 4.43% | 4.43% |
| Vertex Pharmaceuticals Inc | 9.10% | 4.99% | 4.99% |
| Regeneron Pharmaceuticals Inc | 6.21% | 5.47% | 5.47% |
| Alnylam Pharmaceuticals Inc | 3.83% | 3.17% | 3.17% |
| Biogen Inc | 3.63% | 4.79% | 3.63% |
| Illumina Inc | 3.17% | 3.51% | 3.17% |
| United Therapeutics Corp | 2.83% | 4.08% | 2.83% |
| Incyte Corp | 2.49% | 3.06% | 2.49% |
| Neurocrine Biosciences Inc | 2.08% | 2.66% | 2.08% |
| Bio-Techne Corp | 1.54% | 3.73% | 1.54% |
| BioMarin Pharmaceutical Inc | 1.34% | 2.82% | 1.34% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in BBH
- Revolution Medicines Inc — 5.27%
- Argenx SE — 4.97%
- Natera Inc — 4.92%
- IQVIA Holdings Inc — 4.31%
- Moderna Inc — 3.36%
- BeOne Medicines Ltd — 2.81%
- Insmed Inc — 2.67%
- BioNTech SE — 1.94%
- Icon Plc — 1.90%
- Charles River Laboratories International Inc — 1.50%
- Qiagen Nv — 1.06%
- Tempus AI Inc — 0.98%
- State Street Global Advisors — 0.06%
Only in PBE
- Invesco Private Prime Fund — 12.89%
- CareDx, Inc. — 5.04%
- Invesco Private Government Fund — 4.97%
- Royalty Pharma PLC — 4.94%
- Protagonist Therapeutics, Inc. — 3.40%
- Vericel Corp. — 3.27%
- Repligen Corp. — 3.04%
- Acadia Pharmaceuticals Inc. — 3.02%
- Halozyme Therapeutics, Inc. — 2.98%
- Qiagen N.V. — 2.89%
- Exelixis, Inc. — 2.64%
- BioCryst Pharmaceuticals, Inc. — 2.63%
- Veracyte, Inc. — 2.60%
Asset mix
| Asset type | BBH | PBE |
|---|---|---|
| Stocks | 100.0% | 100.1% |
| Cash & short-term funds | 0.1% | 17.9% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Country mix
| Country | BBH | PBE |
|---|---|---|
| US | 87.3% | 108.6% |
| NL | 6.0% | 2.9% |
| GB | — | 4.9% |
| CH | 2.8% | — |
| DE | 1.9% | — |
| IE | 1.9% | — |
| KY | — | 1.6% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jul 31, 2026)
Check another pair
FAQ
How much do BBH and PBE overlap?
What stocks do BBH and PBE have in common?
Should I own both BBH and PBE?
Which holds more stocks, BBH or PBE?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.